
Buditime 0.5mg/2ml Infusion
Marketer
Fibovil Pharmaceuticals Pvt Ltd
Salt Composition
Budesonide (0.5mg/2ml)
Overview Buditime 0.5mg/2ml Infusion
Infusion of Cortizone-S 0.5mg/2ml, a corticosteroid medication, effectively manages irritable bowel syndrome symptoms. Its localized action reduces inflammation, pain, and swelling. This infusion may be administered with or without food; consistent daily dosing is crucial for optimal results. Discontinuing treatment prematurely without consulting a physician may exacerbate symptoms. While generally well-tolerated, potential side effects include mood alterations and gastrointestinal discomfort. Furthermore, Cortizone-S 0.5mg/2ml can impair the body's infection-fighting capabilities; report any infection indicators, like fever or sore throat, to your doctor immediately.
Primary Ingredients of Buditime 0.5mg/2ml Infusion
The provided text is "undefined," offering no content to rephrase.
Uses of Buditime 0.5mg/2ml Infusion
Managing asthma and ulcerative colitis
Major Benefits of Buditime 0.5mg/2ml Infusion:
This medication will be administered by your healthcare provider. Self-medication is not permitted.
Common Side effects of Buditime 0.5mg/2ml Infusion:
- Headache
- Abdominal pain
- Depression
- Joint pain
- Cushing syndrome
- Dyspepsia
- Increased risk of infection
- Muscle pain
- Muscle weakness
- Muscle twitching
- Osteoporosis
- Irritability
- Euphoria (feeling of intense excitement and happiness)
How to use Buditime 0.5mg/2ml Infusion:
This medication will be administered by your healthcare provider. Self-medication is not permitted.
How Buditime 0.5mg/2ml Infusion works:
Riluzole 0.5mg/2ml solution for infusion is a corticosteroid that inhibits the synthesis of inflammatory mediators, thereby reducing symptoms of allergy and inflammation such as redness and edema.
SAFETY ADVICE
AlcoholUNSAFE
Combining Buditime 0.5mg/2ml Infusion and alcohol is contraindicated.
PregnancyCONSULT YOUR DOCTOR
Administering Buditime 0.5mg/2ml Infusion during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Administering Buditime 0.5mg/2ml infusion while breastfeeding appears to pose minimal risk. Available human data indicate negligible infant exposure.
DrivingSAFE
Administering Buditime 0.5mg/2ml intravenously typically has no impact on driving capabilities.
KidneySAFE IF PRESCRIBED
The use of Buditime 0.5mg/2ml Infusion in patients with impaired renal function appears to pose minimal risk. Preliminary findings indicate dose modification for Buditime 0.5mg/2ml Infusion may be unnecessary in this population; however, medical advice is recommended.
LiverCAUTION
Patients with liver impairment should receive Buditime 0.5mg/2ml Infusion cautiously, potentially requiring dose modification. Consult a physician before administration. Buditime 0.5mg/2ml Infusion is contraindicated in patients with severe hepatic dysfunction due to insufficient clinical data.
What if you forget to take Buditime 0.5mg/2ml Infusion :
NA
Facts to Know About Buditime 0.5mg/2ml Infusion
| Label | Value |
|---|---|
| Chemical Category | Inhaled corticosteroids |
| Developing Habits | No. |
| Treatment Category | Breathing |
| Actions | Inhaled Corticosteroids |
